Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct;23(4):883-97.
doi: 10.1016/j.chc.2014.05.002. Epub 2014 Aug 12.

Nutritional supplements for the treatment of ADHD

Affiliations
Review

Nutritional supplements for the treatment of ADHD

Michael H Bloch et al. Child Adolesc Psychiatr Clin N Am. 2014 Oct.

Abstract

Polyunsaturated fatty acid supplementation appears to have modest benefit for improving ADHD symptoms. Melatonin appears to be effective in treating chronic insomnia in children with ADHD but appears to have minimal effects in reducing core ADHD symptoms. Many other natural supplements are widely used in the United States despite minimal evidence of efficacy and possible side effects. This review synthesizes and evaluates the scientific evidence regarding the potential efficacy and side effects of natural supplements and herbal remedies for ADHD. We provide clinicians with recommendations regarding their potential use and role in overall ADHD treatment.

Keywords: Attention-deficit hyperactivity disorder; Gingko biloba; Magnesium; Omega-3 fatty acids; Polyunsaturated fatty acids; Zinc.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors have no conflicts of interest to disclose.

References

    1. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics. . Pediatrics. 2000 May;105(5):1158–1170. - PubMed
    1. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA. 1998 Apr 8;279(14):1100–1107. - PubMed
    1. Spencer T, Biederman J, Wilens T, Harding M, O’Donnell D, Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 1996 Apr;35(4):409–432. - PubMed
    1. Schachter HM, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ. 2001 Nov 27;165(11):1475–1488. - PMC - PubMed
    1. Connor DF, Fletcher KE, Swanson JM. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999 Dec;38(12):1551–1559. - PubMed

Publication types

MeSH terms